Chronic rheumatologic disorders and cardiovascular disease risk in women

Puja K Mehta1, Rebecca D Levit1, Malissa J Wood2

  • 1Emory Women's Heart Center, Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.

Insights

Autoimmune conditions significantly increase cardiovascular disease (CVD) risk in women by accelerating atherosclerosis and thrombosis. Early screening and multidisciplinary care are crucial for managing CVD in this population.

Area of Science:

  • Women's Health
  • Cardiovascular Medicine
  • Rheumatology

Background:

  • Cardiovascular disease (CVD) poses a significant global health threat to women.
  • Autoimmune conditions are emerging as key contributors to CVD complications in women.
  • Chronic inflammation from autoimmune disorders accelerates atherosclerosis, microvascular dysfunction, and thrombosis.

Purpose of the Study:

  • To highlight the role of autoimmune conditions in women's cardiovascular health.
  • To emphasize the impact of autoimmune disease characteristics on CVD risk.
  • To advocate for early CVD risk factor screening in women with autoimmune conditions.

Main Methods:

  • Review of current literature on autoimmune diseases and CVD in women.
  • Analysis of factors influencing CVD risk and progression in this demographic.
  • Discussion of therapeutic implications for managing inflammation and CVD.

Main Results:

  • Autoimmune disorders promote premature atherosclerosis, microvascular issues, and clotting.
  • Comorbidities, disease duration/severity, and inflammation management impact CVD outcomes.
  • Medications like NSAIDs, corticosteroids, DMARDs, and biologics influence CVD risk factors.

Conclusions:

  • Early CVD risk factor identification and screening are vital for women with autoimmune conditions.
  • Comprehensive management strategies, including multidisciplinary care and research, are needed.
  • Further research and clinical trials focusing on systemic autoimmune conditions are essential to improve women's cardiovascular care.

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
30
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.8K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
328
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
450